Deals
Hologic Agrees to Acquire Gen-Probe for $3.7 Billion
This article is for subscribers only.
Hologic Inc., a maker of diagnostic, medical and surgical devices, said the $3.7 billion acquisition of Gen-Probe Inc. will bring “double-digit” returns as the company sells new products to overseas markets.
“We’re very confident that this investment will yield a low double-digit return, and that’s significantly greater than our cost of capital,” Hologic Chief Executive Officer Rob Cascella said in an interview.